Document text
Principal Investigator: Eliver Ghosn
Organization: EMORY UNIVERSITY
Fiscal Year: 2020
Award: $359,677
Funding agency: National Institute of Allergy and Infectious Diseases
SUMMARY
COVID-19 disease is an ongoing global pandemic caused by a new beta-coronavirus SARS-CoV-
2. A major obstacle to battling SARS-CoV-2 is a better understanding of the human innate immune
responses that can lead to an uncontrolled hyper-inflammation in the lung and, ultimately, to an
acute respiratory distress syndrome (ARDS) in some patients but not others. Due to the rapid
emergence of this pandemic, very limited knowledge is available on the lung-specific innate
immune responses to SARS-CoV-2 that could lead to ARDS (and in some cases death) or instead
elicit a protective antiviral response (e.g., type-I interferons, interferon-stimulated genes).
The role of the human innate immune system, particularly the myeloid cells, in initiating a “cytokine
storm” and generalized hyper-inflammation has been reported, but specifically how lung-resident
macrophages vs. infiltrating monocytes differentially respond to SARS-CoV-2 and how each
myeloid subset contribute to either protective antiviral responses or uncontrolled hyper-
inflammation and ARDS remain unknown. Hence, an in-depth study of the myeloid compartment
in the lung and blood of severe COVID-19 patients in ICU is critical to better understand the
initiation and persistence of ARDS and, most importantly, to the development of more efficient
and targeted therapy.
Our project’s primary objective is to resolve, at a single-cell level, the specific myeloid subsets,
including lung-resident alveolar and interstitial macrophages, dendritic cells, as well as infiltrating
blood monocytes, that are responsible for protective antiviral responses (e.g., type-I interferons,
interferon-stimulated genes) and/or aberrant hyper-inflammatory responses that lead to ARDS
(e.g., “cytokine storm”, neutrophil recruitment, etc.). Through these studies, we will develop novel
insights into the molecular programming and heterogeneity of the human innate immune
responses to SARS-CoV-2 infection and identify potential target genes to inform effective
treatment strategies.
Terms: <2019 novel coronavirus><2019-nCoV><3-10C><AMCF-I><ARDS><Acute Respiratory Distress><Acute Respiratory Distress Syndrome><Adult ARDS><Adult RDS><Adult Respiratory Distress Syndrome><Affect><Alveolar><Alveolar Macrophages><Anti-Viral Response><Antibodies><Antibody titer measurement><Antiviral Agents><Antiviral Drugs><Antiviral Response><Antivirals><Aspirate><Aspirate substance><Assay><Bioassay><Biologic Assays><Biological Assay><Blood><Blood Reticuloendothelial System><Blood Sample><Blood monocyte><Blood specimen><Body Tissues><Bone Marrow><Bone Marrow Reticuloendothelial System><Bronchoalveolar Lavage Fluid><COVID-19><COVID19><CXCL8><Cell Body><Cells><Cessation of life><Chemotactic Cytokines><CoV emergence><Coronaviridae><Coronavirus><Critical Illness><Critically Ill><Da Nang Lung><Data Set><Dataset><Death><Dendritic Cells><Development><Disease><Disease Outcome><Disorder><Expression Profiling><Expression Signature><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Follow-Up Studies><Followup Studies><Funding><GCP1><Gene Expression><Gene Expression Profile><Genes><Grant><Grippe><Heterogeneity><Homologous Chemotactic Cytokines><Human><IFN><IL-8><IL8><IL8 gene><Immune><Immune mediated therapy><Immunes><Immunologically Directed Therapy><Immunotherapy><Individual><Infection><Infiltration><Inflammation><Inflammatory><Inflammatory Response><Influenza><Innate Immune Response><Innate Immune System><Intensive Care Units><Intercrines><Interferon Type I><Interferons><Investigation><K60><Knowledge><Label><Lead><Life><Ligands><Lung><Lung Respiratory System><Lymphoid Cell><Marrow monocyte><Measures><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Modern Man><Molecular><Myelogenous><Myeloid><Myeloid Cells><NIAID><National Institute of Allergy and Infectious Disease><Neutrophil Infiltration><Neutrophil Recruitment><Oligo><Oligonucleotides><Outcome><Patients><Pb element><Phenotype><Play><Population><Public Health><Pulmonary Macrophages><RNA Viruses><Receptor Protein><Reporting><Research><Role><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><SCYB8><SIS cytokines><Severe acute respiratory syndrome coronavirus 2><Shock Lung><Sputum><Stiff lung><Surface Proteins><Symptoms><T cell response><TSG-1><Tissues><Veiled Cells><Viral><Viral Antibodies><Virus><Virus Replication><Wuhan coronavirus><Yolk Sac><anti-viral agents><anti-viral antibody><anti-viral drugs><anti-virals><antibody titering><antiviral antibody><b-ENAP><base><cell type><chemoattractant cytokine><chemokine><corona virus><corona virus disease 2019><coronavirus disease 2019><coronavirus emergence><cytokine release syndrome><cytokine storm><developmental><effective therapy><effective treatment><emergent CoV><emergent coronavirus><emerging CoV><emerging coronavirus><endotracheal><experience><fetal><flow cytophotometry><flu infection><gene expression pattern><gene expression signature><heavy metal Pb><heavy metal lead><high dimensionality><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunopathology><influenza infection><insight><interstitial><macrophage><monocyte><nCoV><new CoV><new coronavirus><novel><novel CoV><novel coronavirus><oligos><pandemic><pandemic disease><progenitor><pulmonary><receptor><recruit><respiratory><response><scRNA-seq><single cell RNA-seq><single cell RNAseq><single-cell RNA sequencing><social role><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><transcriptional signature><treatment strategy><viral multiplication><viral replication><virus multiplication><vitelline sac><wet lung>